Showing a limited preview of this publication:
This article examines Aubrey de Grey's case for allocating substantial funding to interventive biogerontological research immediately. The conclusion is that the case is inconclusive and that scientific analyses of costs and probabilities would be needed to defend it properly.
Published Online: 2008-1-16
©2011 Walter de Gruyter GmbH & Co. KG, Berlin/Boston
